BSX vs ITGR
BSX: Boston Scientific is a leading medical device company dedicated to transforming lives through innovative, less-invasive medical solutions for a broad range of interventional specialties. ITGR: Integer Holdings is a leading medical device outsource manufacturer supplying critical components and complex assemblies to global OEMs in the cardiac and neuromodulation sectors.
Side-by-side fundamentals
| Metric | BSX | ITGR | Edge |
|---|---|---|---|
| Price as of 2026-10-21 close | $44.51 | $126.70 | |
| Market cap as of 2026-07-30 (share count; price 2026-10-21) | $64.5B | $4.3B | |
| P/E as of 2026-10-21 | 18.02 | 34.71 | BSX lower |
| PEG as of 2026-10-21, 3-year EPS CAGR to FY2025 | 0.29 | 2.62 | BSX lower |
| Net margin FY2025, SEC XBRL | +14.4% | +5.5% | BSX higher |
| Gross margin FY2025, SEC XBRL | +69.0% | +27.0% | BSX higher |
| Operating margin FY2025, SEC XBRL | +18.0% | +11.9% | BSX higher |
| ROE FY2025, SEC XBRL | +11.8% | +5.9% | BSX higher |
| ROA FY2025, SEC XBRL | +6.6% | +3.0% | BSX higher |
| Debt / equity | 0.51 | 0.72 | BSX lower |
| Revenue growth (YoY) FY2025, SEC XBRL | +19.9% | +8.0% | BSX higher |
| Revenue CAGR (3y) SEC XBRL | +16.5% | +11.7% | BSX higher |
| Dividend streak (yrs) SEC XBRL | 0 | 0 | Tie |
| Beta as of 2026-09-03 | 0.57 | 0.76 | |
| 1-year return as of 2026-10-21 close | -55.4% | +17.4% | ITGR higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.